IPercept Raises $16.5M Series A Led by 2150 for Industrial Predictive AI

IPercept Raises $16.5M Series A

IPercept, a Stockholm-based industrial AI company, has raised $16.5 million in Series A funding. The round was announced on September 29, 2026, and was led by 2150.

What IPercept Does

IPercept provides a predictive AI platform for manufacturers. The platform enables machine monitoring and diagnostics without requiring system integration or infrastructure changes.

According to the company, its patented technology allows manufacturers to monitor machine health without adding new sensors. This approach delivers rapid deployment and actionable insights within days of implementation.

Company Background

IPercept was founded after five years of research at the Royal Institute of Technology.

Funding Details

• Round type: Series A
• Amount: USD 16,500,000
• Announced: September 29, 2026
• Lead investor: 2150
• Investors: AI Fund, J12 Ventures, 2150, RunwayFBU, Luminar Ventures, Isogon Ventures

Why It Matters

Industrial predictive maintenance has long been constrained by the cost and complexity of instrumentation — adding sensors, integrating with existing systems, and standing up new infrastructure. IPercept's proposition is to remove those barriers: monitor machine health without new sensors and without system integration, with insights available within days.

That combination — patented technology, no-hardware deployment, and fast time-to-value — targets a core pain point for manufacturers who want predictive capabilities but are unwilling or unable to undertake lengthy retrofit projects.

The investor syndicate reflects a mix of industrial, venture, and deep-tech backers. 2150 leads the round, with participation from AI Fund, J12 Ventures, RunwayFBU, Luminar Ventures, and Isogon Ventures.

Acquisition Angle

For acquirers in industrial software, manufacturing technology, or industrial IoT, IPercept offers a predictive AI platform with a differentiated deployment model. The absence of required sensors and system integration lowers adoption friction and shortens sales cycles — attractive characteristics for a platform looking to scale across manufacturing customers.

The company's roots in research at the Royal Institute of Technology provide technical credibility, while its Stockholm base positions it within the Nordic industrial technology ecosystem.

Strategic buyers seeking to add machine monitoring and diagnostics capabilities — particularly those serving manufacturers — may view IPercept as a tuck-in or platform asset. The Series A capital provides runway to expand deployment and commercial reach.

Summary

IPercept has raised $16.5 million in Series A funding led by 2150, announced September 29, 2026, with participation from AI Fund, J12 Ventures, RunwayFBU, Luminar Ventures, and Isogon Ventures. The Stockholm-based company provides a predictive AI platform for manufacturers, enabling machine monitoring and diagnostics without system integration or new sensors.